W. L. Gore & Associates, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$33Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
22,348clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $7.4M
2020 $3.1M
2021 $2.5M
2022 $4.5M
2023 $5.1M
2024 $4.9M
2025 $5.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Vascular Surgery $12M
Surgery $7.1M
Interventional Cardiology $2.7M
Thoracic Surgery (Cardiothoracic Vascular Surgery) $2.6M
Cardiovascular Disease $1.7M
Pediatric Cardiology $1.4M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Sapan Desai Arlington Heights, IL Vascular Surgery $1,164,528.59
Esen Akpek Baltimore, MD Ophthalmology $627,754.07
Matthew Goldblatt Milwaukee, WI Surgery $534,174.91
Joseph Bavaria Allentown, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $500,558.06
Ross Milner Chicago, IL Vascular Surgery $385,578.98
Darren Schneider Philadelphia, PA Vascular Surgery $384,902.89
Sukgu Han Los Angeles, CA Vascular Surgery $365,303.39
Gagan Singh Sacramento, CA Cardiovascular Disease $362,097.76
Brant Heniford Charlotte, NC Surgery $346,077.00
John Fischer Philadelphia, PA Plastic Surgery $319,795.09

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.